Acta Neurologica Scandinavica · 2009 · 14 citations · 2 references
Life SciencesImmunologyNeurologyAutoimmunityImmunopathologyNeuroimmunologyAntibody CharacterizationAutoimmune DiseasesCerebrospinal Fluid ImmunologyMultiple SclerosisAntibody-mediated Neurologic DiseaseImmune-mediated PathogenesisLymphocytic InfiltratesLymphocytic InflammationMultiple Sclerosis ImmunopathogenesisMultiple Sclerosis ImmunopathologyMultiple Sclerosis PathologySerum Total Protein
Statistical analysis of clinical data (sex, clinical stage, and age of the disease) and biological data (CSF total protein, albumin and gammaglobulins by electrophoresis, lymphocytes count) from a population of 326 MS patients (115 men and 211 women) suggests that MS is a two-phase disease. The early phase is probably an intermittent and intrathecal synthesis of antibodies linked to a lymphocytic pleiocytosis: this acute intermittent process may represent a local immuno-logical reaction against a virus. The second phase, on the other hand, is a continuous synthesis of antibodies with simultaneous increase of albumin in CSF and disappearance of any lymphocytic pleiocytosis: the probability being in favour of a synthesis of antibodies out of the CNS (in peripheral lymphoid organs), in other words, of an autoimmune process.
2
The course of multiple sclerosis in 73 cases with computer-designed curves.
Fog T, F Linnemann · PubMed · 1970 · 74 citations